©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 112062
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112062
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112062
Figure 1 Agari-5 restored cardiac function after myocardial infarction in rats.
A: Overall experimental flowchart; B: Cardiac ultrasound of rats in each group (n = 3 hearts/group); C: Statistical histograms of ejection fraction, fractional shortening, left ventricular end-diastolic dimension, and left ventricular end-systolic dimension data of cardiac ultrasound in rats of each group. All data are expressed as mean ± SD. All statistics are shown in bar graphs. aP < 0.05. EF: Ejection fraction; FS: Fractional shortening; LVIDs: Left ventricular end-systolic dimension; LVIDd: Left ventricular end-diastolic dimension; MI: Myocardial infarction; NS: Not significant.
- Citation: Zhao YB, Bao ZH, Tu Y, Qiu X, Bao YL, Su M, Qi HJ, Wan Q. Proteomics-based investigation of the protective effect and mechanism of Agari-5 in rats with myocardial infarction. World J Cardiol 2025; 17(12): 112062
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/112062.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.112062